Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Akero Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| Security |
Security Class Title |
Fee Calculation or Carry Forward |
Amount Registered |
Proposed Maximum Offering Per Unit |
Maximum |
Fee Rate |
Amount of Registration |
Carry Forward Form Type |
Carry Forward File Number |
Carry Forward Initial effective date |
Filing Fee Previously Paid In Connection with Unsold Securities to be Carried Forward | |||||||||||||
| Fees to Be Paid |
Equity |
Common Stock, $0.0001 par value per share |
Rule 457(r) (1) |
5,238,500 |
$42.00 |
$220,017,000.00 |
0.0001102 |
$24,245.88 |
— |
— |
— |
— | ||||||||||||
| Fees Previously Paid |
||||||||||||||||||||||||
|
Carry Forward Securities | ||||||||||||||||||||||||
| Carry Forward Securities |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— |
— | |||||||||||||
| Total Offering Amounts | $220,017,000.00 |
$24,245.88 |
||||||||||||||||||||||
| Total Fees Previously Paid | — |
|||||||||||||||||||||||
| Total Fee Offsets | — |
|||||||||||||||||||||||
| Net Fee Due |
$24,245.88 |
|||||||||||||||||||||||
| (1) | Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended. Represents deferred payment of the registration fees in connection with the registrant’s Registration Statement on Form S-3ASR (Registration No. 333-256229) being paid herewith. |